Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 786.60
Bid: 787.60
Ask: 788.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.051%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 786.60
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

10-Month Trading Update

11 Nov 2019 07:00

RNS Number : 8852S
Informa PLC
11 November 2019
 

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

11 November 2019

Ten-Month Trading Update

Resilient Performance & Continuing Growth

London: Informa (LSE: INF.L), the International Exhibitions, Events, Information Services and Advanced Learning Group, today issued a trading update for the 10-month period ending 31 October 2019.

Key Highlights

·; Performance…Continued growth in revenue, adjusted profit, earnings and cashflow; full year performance on track;

·; Growth…Group underlying revenue growth of 2.8% for the ten months to 31 October 2019, ahead of significant, seasonally stronger November/December trading period;

·; Focus…Progressive Portfolio Management continues with divestiture of Industry & Infrastructure Media Brands Portfolio, following on from sale of Life Sciences Media Brands Portfolio and Agribusiness Portfolio, as well as portfolio changes in Informa Connect;

·; Expansion…Minority investment in Founders Forum and launch of joint venture with Informa Tech, combining strengths to support next phase of growth in tech innovation and entrepreneurship;

·; Strength…Issue of new €500m bond further strengthens balance sheet, lowering overall cost of debt and extending average maturity to 5.5 years.

Stephen A. Carter, Group Chief Executive, Informa PLC, said:

"After ten months trading in 2019, despite an unpredictable economic/geo-political backdrop, the enlarged Informa Group continues to demonstrate resilience and performance, remaining on track for a sixth consecutive year of growth in underlying revenue, profit, adjusted earnings and cashflow."

2019 Ten-Month Trading Highlights

Following the successful combination with UBM through the Accelerated Integration Plan, Informa has continued to perform well, with underlying revenue growth for the 10-month period to 31 October 2019 at 2.8%. This reflects a good underlying performance, balanced against strong comparable growth in the third quarter last year, fewer of our major brands operating in the period and two market-specific, in-year impacts within Informa Markets in Hong Kong and Dubai.

November and December are significant trading months for the enlarged Informa Group, representing around 20% of annual revenue, with November alone accounting for more than £350m. This includes a key period for subscription renewals and consulting business at Informa Intelligence, Informa Tech and Taylor & Francis, whilst we also run a number of major event Brands through the period, including in Pharma & Healthcare (CPhI Worldwide, CPhI India, BioEurope) and Technology (AI Summit, AfricaCom, Blackhat Europe).

Despite ongoing economic/geo-political uncertainty, our forward pacing for the remainder of 2019 provides reassurance on our Group revenue guidance of 3.5% for the year. Furthermore, the breadth and balance of the enlarged Group, the quality of our revenue growth and strong visibility of forward bookings and renewals into the first quarter of 2020 gives us confidence in the strength and resilience of future growth.

Informa Markets…specialist international B2B platforms for trade and commerce

Our international scale and depth in a range of attractive and growing specialist B2B markets delivered strong performances through the third quarter in Health & Nutrition (SupplySide West), Hospitality, Food & Beverage (Hotelex) and Design & Furniture (Furniture China), amongst others.

We are also continuing to see good progress in the Fashion portfolio following the launch of the Fashion GAP Plan, stemming the historical decline in attendance over previous years, improving NPS scores and successfully launching OneMagic. This is laying the foundation for further improvement in 2020, supporting our target to return the Fashion portfolio to growth by 2021.

The Group had two market-specific, in-year impacts through the period: in Dubai, increasing commitment to World Expo 2020, combined with challenging market conditions, has had a significant effect on traditional exhibitions investment, particularly in Real Estate & Construction, impacting Cityscape Global, in September. In Hong Kong, where we generate around 4% of Group revenue, recent civil protests have had a small impact on revenue growth at some events. This affected our largest brand in the region during September, the Hong Kong Jewellery & Gem Show, although a strong programme of support, including investment in additional security and transport, ensured the show still ran effectively.

The underlying performance of Informa Markets was strong in the first 10-months of the year, despite these impacts in Dubai and Hong Kong, delivering 3.4% underlying revenue growth across the period.

A number of our largest and fastest growing Brands operate through the last two months of the year and forward bookings are on track, most notably in Pharma (CPhI Worldwide, Food Ingredients Europe, CPhI India), and Maritime, Transportation & Logistics (Marintec, Fort Lauderdale International Boat Show). This will lead to a re-acceleration in growth through to year-end, although given the two, in-year impacts, growth for the year is now expected to be 4.5%- rather than 4.5%+.

Informa Connect…international B2B communities for learning and engagement

Our focus on high quality brands in attractive specialist markets continues to deliver improved growth in 2019, with underlying revenue growth increasing from 2.1% after six months to 2.8% after ten months, with strong recent performances in both Global Finance (Finovate Fall, SuperReturn Asia) and Life Sciences (BioProcess International, BioPharm America).

With forward pacing trends positive and confidence in our major brands, including in Marketing (TMRE) and Life Sciences (BioEurope), this leaves us well placed to meet or beat our 2.5% underlying revenue growth target for the year.

Informa Connect specialises in developing highly curated content and strong professional networks and communities. As a consequence, through the Progressive Portfolio Management ("PPM") programme, we have been realigning our events portfolios to take advantage of this skill set, combining our more content curated events such as our Canadian events portfolio into Informa Connect. This particular business has annual revenues of around £40m and operates content-rich Branded Conferences, Confexes and Consumer-led events in a range of specialist communities and sectors.

Informa Tech…specialist B2B services and solutions for the technology industry

In 2019, the priority for Informa Tech is establishing itself as a market-focused business with B2B products and services in events, research, consulting, data and media, a strong position in a range of Technology sub-sectors and annual revenues of close to £300m.

Following the addition of IHS Markit's TMT Portfolio in August, today we have made a minority investment in and launched a joint venture with Founders Forum, the leading community for entrepreneurs, investors and leaders in the Digital, Media and Technology markets. It brings a unique brand and high-profile connections in attractive, fast growth segments and will support the next phase of growth in technology innovation and entrepreneurship, including the continued expansion of London Tech Week.

We are planning for growth in all key segments of the market, from Enterprise IT to The Internet of Things. This is reflected in our progress through 2019, with strong recent performances in Security (Blackhat) and Artificial Intelligence (AI Summit) delivering 10-month underlying revenue growth of 1.7%, against a full year target of 2%.

As well as a steady performance in 2019, we continue to build for the future, developing a compelling customer proposition as a combined business, for 2020 and beyond.

Informa Intelligence…specialist B2B insight and intelligence

Following a period of major restructuring and reinvestment through the Growth Acceleration Plan, the business is now performing consistently, with improving levels of growth in its specialist markets of Pharma, Retail Banking and Maritime.

Strong renewal rates and robust new business performance through the primary subscriptions season laid a solid foundation for further growth, and we are seeing this continue in the second half of the year, with underlying revenue growth for the 10-month period of 3.1%.

Annualised contract values continue to grow steadily, providing forward visibility alongside a strong pipeline for project consulting and other contingent revenues. We remain on track to meet or beat our 3% underlying growth target for the year.

As part of the PPM programme, today we have announced the divestiture of our Industry & Infrastructure Media Brands Portfolio to Endeavor Business Media. This is a collection of largely advertising-funded information brands serving industrial markets, including Industry Week, New Equipment Digest and Machine Design. The sale brings total annualised revenues of businesses we have divested through PPM within the range of the targeted £150m.

Taylor & Francis…scholarly publishing and specialist reference-led content

Against a backdrop of robust underlying demand for specialist knowledge and ongoing evolution in product formats and distribution models, Taylor & Francis continues to perform consistently.

Our approach is to remain flexible, balancing customer needs with maintaining the overall quality and integrity of our content. This strategy continues to deliver steady, modest growth, underpinned by robust and predictable subscription revenues and good growth in Open Access services. Books revenue continues to be more transactional in nature and, after delivering strong growth in 2018 on the back of our Operational Improvement Programme, 2019 has a particularly tough comparable.

In the ten-month period to 31 October, we delivered underlying revenue growth of 1.8%, consistent with the run-rate reported at the half-year stage. With a clear pipeline of activity in the last two months of the year, we remain confident in our annual target of 2% underlying growth.

Enquiries

 

Informa PLC

Stephen A. Carter, Group Chief Executive

Gareth Wright, Group Finance Director

Richard Menzies-Gow, Director of IR & Comms

 

+44 (0)20 7017 5771

+44 (0)20 7017 7096

+44 (0)20 3377 3445

Teneo Strategy

Tim Burt / Zoë Watt

 

+44 (0)20 7240 2486

Analyst and Investors

Gareth Wright, Group Finance Director, and Richard Menzies-Gow, Director of Investor Relations, will be hosting a short conference call for analysts and investors today to discuss the Trading Update, commencing at 09:00 UK time. Dial-in details: +44 (0)330 336 9104 / Confirmation Code: 691843.

Notes to Editors

Informa PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group with annual revenues approaching £3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFFILSLILIA
Date   Source Headline
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20244:45 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20244:16 pmRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:00 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20249:59 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:12 pmRNSInforma 2023 Full Year Results Replacement
8th Mar 20247:00 amRNSInforma 2023 Full Year Results
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.